Citations

Showing 10 of 108081 citations.

Hospitalist perspective on pandemic related clinical and administrative changes: a cross sectional survey study
Aksoy, Tulay , Patil, Nikita , Baron, Sarah , Gambhir, Harvir Singh , Mandel, Chiara , Pagali, Sandeep R. , Baron, Sarah W , Pagali, Sandeep

Mayo Clinic

Hospital Practice | April 21, 2023 | Volume: 51 | Issue: 3 | Pages: 149-154

10.1080/21548331.2023.2206230 | PMID 37083176 Get It

The yin and yang of GSM and low sexual desire
Kingsberg, Sheryl A. , Adler, B., Metropoulos, J., Metropoulos, J., Faubion, Stephanie S.

Mayo Clinic

Climacteric | April 21, 2023 | Volume: 26 | Issue: 4 | Pages: 323-328

10.1080/13697137.2023.2194529 | PMID 37083058 Get It

Letter: Incisional Wound Vacuum—Evaluation of Wound Outcomes in Comparison With Standard Dressings for Posterior Spinal Fusions in Traumatic Patients
Kuo, Cathleen C. , Gendreau, Julian , Brown, Nolan J. , Mehkri, Yusuf , Rahmathulla, Gazanfar

Mayo Clinic

Operative Neurosurgery | April 21, 2023 | Volume: 25 | Issue: 1 | Pages: e63-e63

10.1227/ons.0000000000000736 | PMID 37083503 Get It

Causes of Early Mortality After Catheter Ablation of Atrial Fibrillation
Tan, Min Choon , Karikalan, Suganya Arunachalam , Deshmukh, Abhishek , Srivathsan, Komandoor , Scott, Luis R. , McLeod, Christopher J. , Asirvatham, Samuel J. , Noseworthy, Peter A. , Mulpuru, Siva K. , Cha, Yong‐Mei , Munger, Thomas M. , Lee, Justin Z. , Karikalan, Suganya , Deshmukh, Abhishek J , Srivathsan, Komandoor , Scott, Luis R , McLeod, Christopher J , Asirvatham, Samuel J , Noseworthy, Peter A , Deshmukh, Abhishek J , Tan, Min C , Rattanawong, Pattara

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | April 21, 2023 | Volume: 16 | Issue: 5 | Pages: No page available

10.1161/circep.122.011365 | PMID 37082954 Get It

Background: Recognition of the causes of early mortality after atrial fibrillation (AF) catheter ablation is essential for the improvement of patient safety. This study sought to determine the causes of early mortality (≤90 days) after AF ablation. Methods: We performed a retrospective analysis of AF ablation from January 1, 2013, to December 1, 2021 at the Mayo Clinic (Rochester, Phoenix, and Jacksonville). Causes of death were identified through a comprehensive chart review of the electronic health record from within the Mayo Clinic system and outside records when available. Results: A total of 6723 patients were included in the study. The 90-day all-cause mortality rate was 0.22% (n=15). Among all 90-day deaths, majority of the deaths (73.3%) did not have a direct relationship with the procedure. Sudden death was the most common cause of early death (20%), followed by peri-procedural stroke (13%), respiratory failure (13%), atrioesophageal fistula (13%), infection (7%), heart failure (7%), and traumatic brain injury (7%). The 90-day mortality rate directly due to AF ablation procedural complications was 0.06% (n=4). Conclusions: AF ablation procedure has a 90-day mortality of 0.22%, and the most common cause of early mortality was sudden death. The majority (73.3%) of early mortality was not directly associated with a procedural complication, and the mortality rate due to complications associated with the AF ablation procedure was low at 0.06%. Further studies are required to investigate causes and risk factors associated with sudden death in this patient population.
Craniovertebral Junction Instability after Oncological Resection: A Narrative Review
Ottenhausen, Malte , Greco, Elena , Bertolini, Giacomo, Gerosa, Andrea , Ippolito, Salvatore, Middlebrooks, Erik H. , Serrao, Graziano , Costa, Francesco , Corte, Emanuele La , La Corte, Emanuele , Middlebrooks, Erik H , Greco, Elena , Ippolito, Salvatore, Bruzzone, Maria Grazia , Ferroli, Paolo

Mayo Clinic

Diagnostics | April 21, 2023 | Volume: 13 | Issue: 8 | Pages: 1502

10.3390/diagnostics13081502 | PMID 37189602 Get It

The craniovertebral junction (CVJ) is a complex transition area between the skull and cervical spine. Pathologies such as chordoma, chondrosarcoma and aneurysmal bone cysts may be encountered in this anatomical area and may predispose individuals to joint instability. An adequate clinical and radiological assessment is mandatory to predict any postoperative instability and the need for fixation. There is no common consensus on the need for, timing and setting of craniovertebral fixation techniques after a craniovertebral oncological surgery. The aim of the present review is to summarize the anatomy, biomechanics and pathology of the craniovertebral junction and to describe the available surgical approaches to and considerations of joint instability after craniovertebral tumor resections. Although a one-size-fits-all approach cannot encompass the extremely challenging pathologies encountered in the CVJ area, including the possible mechanical instability that is a consequence of oncological resections, the optimal surgical strategy (anterior vs posterior vs posterolateral) tailored to the patient’s needs can be assessed preoperatively in many instances. Preserving the intrinsic and extrinsic ligaments, principally the transverse ligament, and the bony structures, namely the C1 anterior arch and occipital condyle, ensures spinal stability in most of the cases. Conversely, in situations that require the removal of those structures, or in cases where they are disrupted by the tumor, a thorough clinical and radiological assessment is needed to timely detect any instability and to plan a surgical stabilization procedure. We hope that this review will help shed light on the current evidence and pave the way for future studies on this topic.
A Review of Voice-Based Pain Detection in Adults Using Artificial Intelligence
Borna, Sahar , Haider, Clifton R. , Maita, Karla C. , Velasquez, Gioacchino D. De Sario , Carter, Rickey E. , Forte, Antonio J. , De Sario Velasquez, Gioacchino D, Bruce, Charles J. , Carter, Rickey E , Forte, Antonio Jorge , De Sario, Gioacchino D , Borna, Sahar , Torres‐Guzman, Ricardo A. , Ávila, Francisco R. , Garcia, John P. , McLeod, Christopher J.

Mayo Clinic

Bioengineering | April 21, 2023 | Volume: 10 | Issue: 4 | Pages: 500

10.3390/bioengineering10040500 | PMID 37106687 Get It

Pain is a complex and subjective experience, and traditional methods of pain assessment can be limited by factors such as self-report bias and observer variability. Voice is frequently used to evaluate pain, occasionally in conjunction with other behaviors such as facial gestures. Compared to facial emotions, there is less available evidence linking pain with voice. This literature review synthesizes the current state of research on the use of voice recognition and voice analysis for pain detection in adults, with a specific focus on the role of artificial intelligence (AI) and machine learning (ML) techniques. We describe the previous works on pain recognition using voice and highlight the different approaches to voice as a tool for pain detection, such as a human effect or biosignal. Overall, studies have shown that AI-based voice analysis can be an effective tool for pain detection in adult patients with various types of pain, including chronic and acute pain. We highlight the high accuracy of the ML-based approaches used in studies and their limitations in terms of generalizability due to factors such as the nature of the pain and patient population characteristics. However, there are still potential challenges, such as the need for large datasets and the risk of bias in training models, which warrant further research.
Long‐term quality of life after treatment in sinonasal malignancy: A prospective, multicenter study
Maoz, Sabrina L. , Hwang, Peter H. , Fleseriu, Cara M. , Chan, Erik P., Adappa, Nithin D. , Getz, Anne E., Humphreys, Ian M. , Chang, Eugene H. , Jafari, Aria , Kingdom, Todd T. , Kohanski, Michael A. , Lee, Jivianne K., Lazor, Jillian W. , Nabavizadeh, Ali , Adappa, Nithin D. , Patel, Zara M. , Smith, Timothy L. , Storm, Phillip B. , Suh, Jeffrey D. , Wang, Marilene B. , Sim, Myung‐Shin , Wang, Eric W , Choby, Garret , Kuan, Edward C , Humphreys, Ian M , Jafari, Aria , Nayak, Jayakar V , Patel, Zara , Smith, Timothy L , Snyderman, Carl H , Beswick, Daniel , Hwang, Peter H , Maoz, Sabrina L , Choby, Garret , Chan, Erik, Adappa, Nithin D. , Geltzeiler, Mathew , Le, Christopher H. , Abuzeid, Waleed M. , Lee, Jivianne K., Nayak, Jayakar V. , Pinheiro‐Neto, Carlos , Resnick, Adam , John, Maie A. St. , Beswick, Daniel M.

Mayo Clinic

International Forum of Allergy & Rhinology | April 21, 2023 | Volume: 13 | Issue: 11 | Pages: 2030-2042

10.1002/alr.23171 | PMID 37082883 Get It

AbstractBackgroundQuality of life (QOL) for individuals with sinonasal malignancy (SNM) is significantly under‐studied, yet it is critical for counseling and may impact treatment. In this study we evaluated how patient, treatment, and disease factors impact sinonasal‐specific and generalized QOL using validated metrics in a large cohort over a 5‐year posttreatment time frame.MethodsPatients with SNM who underwent definitive treatment with curative intent were enrolled in a prospective, multisite, longitudinal observational study. QOL was assessed using the 22‐item Sino‐Nasal Outcome Test (SNOT‐22) and University of Washington Quality of Life Questionnaire (UWQOL) instruments at pretreatment baseline and multiple follow‐ups through 5 years posttreatment. Multivariable modeling was used to determine demographic, disease, and treatment factors associated with disease‐specific and generalized physical and social/emotional function QOL.ResultsOne hundred ninety‐four patients with SNM were analyzed. All QOL indices were impaired at pretreatment baseline and improved after treatment. SNOT‐22 scores improved 3 months and UWQOL scores improved 6 to 9 months posttreatment. Patients who underwent open compared with endoscopic tumor resection had worse generalized QOL (p < 0.001), adjusted for factors including T stage. Pterygopalatine fossa (PPF) involvement was associated with worse QOL (SNOT‐22, p < 0.001; UWQOL Physical dimension, p = 0.02). Adjuvant radiation was associated with worse disease‐specific QOL (p = 0.03). Neck dissection was associated with worse generalized physical function QOL (p = 0.01). Positive margins were associated with worse generalized social/emotional function QOL (p = 0.01).ConclusionDisease‐specific and generalized QOL is impaired at baseline in patients with SNM and improves after treatment. Endoscopic resection is associated with better QOL. PPF involvement, adjuvant radiation, neck dissection, and positive margins were associated with worse QOL posttreatment.
Leveraging Exosomes as the Next-Generation Bio-Shuttles: The Next Biggest Approach against Th17 Cell Catastrophe
Samarpita, Snigdha , Li, Xiaogang

Mayo Clinic

International Journal of Molecular Sciences | April 21, 2023 | Volume: 24 | Issue: 8 | Pages: 7647

10.3390/ijms24087647 | PMID 37108809 Get It

In recent years, the launch of clinical-grade exosomes is rising expeditiously, as they represent a new powerful approach for the delivery of advanced therapies and for diagnostic purposes for various diseases. Exosomes are membrane-bound extracellular vesicles that can act as biological messengers between cells, in the context of health and disease. In comparison to several lab-based drug carriers, exosome exhibits high stability, accommodates diverse cargo loads, elicits low immunogenicity and toxicity, and therefore manifests tremendous perspectives in the development of therapeutics. The efforts made to spur exosomes in drugging the untreatable targets are encouraging. Currently, T helper (Th) 17 cells are considered the most prominent factor in the establishment of autoimmunity and several genetic disorders. Current reports have indicated the importance of targeting the development of Th17 cells and the secretion of its paracrine molecule, interleukin (IL)-17. However, the present-day targeted approaches exhibit drawbacks, such as high cost of production, rapid transformation, poor bioavailability, and importantly, causing opportunistic infections that ultimately hamper their clinical applications. To overcome this hurdle, the potential use of exosomes as vectors seem to be a promising approach for Th17 cell-targeted therapies. With this standpoint, this review discusses this new concept by providing a snapshot of exosome biogenesis, summarizes the current clinical trials of exosomes in several diseases, analyzes the prospect of exosomes as an established drug carrier and delineates the present challenges, with an emphasis on their practical applications in targeting Th17 cells in diseases. We further decode the possible future scope of exosome bioengineering for targeted drug delivery against Th17 cells and its catastrophe.
Ulnar Nerve Transposition Is Justified in the Treatment of Distal Humerus Fracture
Barlow, Jonathan D. , Barlow, Jonathan

Mayo Clinic

Journal of Orthopaedic Trauma | April 21, 2023 | Volume: 37 | Issue: 5 | Pages: e232-e233

10.1097/bot.0000000000002588 | PMID 37081697 Get It

Utilization of Circulating Tumor Cells in the Management of Solid Tumors
Kurniali, Peter C., Storandt, Michael H. , Jin, Zhaohui , Jin, Zhaohui

Mayo Clinic

Journal of Personalized Medicine | April 21, 2023 | Volume: 13 | Issue: 4 | Pages: 694

10.3390/jpm13040694 | PMID 37109080 Get It

Circulating tumor cells (CTCs) are tumor cells shed from the primary tumor into circulation, with clusters of CTCs responsible for cancer metastases. CTC detection and isolation from the bloodstream are based on properties distinguishing CTCs from normal blood cells. Current CTC detection techniques can be divided into two main categories: label dependent, which depends upon antibodies that selectively bind cell surface antigens present on CTCs, or label-independent detection, which is detection based on the size, deformability, and biophysical properties of CTCs. CTCs may play significant roles in cancer screening, diagnosis, treatment navigation, including prognostication and precision medicine, and surveillance. In cancer screening, capturing and evaluating CTCs from peripheral blood could be a strategy to detect cancer at its earliest stage. Cancer diagnosis using liquid biopsy could also have tremendous benefits. Full utilization of CTCs in the clinical management of malignancies may be feasible in the near future; however, several challenges still exist. CTC assays currently lack adequate sensitivity, especially in early-stage solid malignancies, due to low numbers of detectable CTCs. As assays improve and more trials evaluate the clinical utility of CTC detection in guiding therapies, we anticipate increased use in cancer management.